α2-MO and NCX4a-MO injections disrupt fluid flow in KV
| Treatment . | # of successful bead injections . | # of embryos with strong KV flow . | # of embryos without KV flow . |
|---|---|---|---|
| CTL-MO | 16 | 16 (100%) | 0 (0%) |
| α2-MO | 42 | 1 (2%) | 41 (98%) |
| NCX4a-MO | 19 | 2 (11%) | 17 (89%) |
| α2-MO+KN62 | 24 | 17 (71%) | 7 (29%) |
| Treatment . | # of successful bead injections . | # of embryos with strong KV flow . | # of embryos without KV flow . |
|---|---|---|---|
| CTL-MO | 16 | 16 (100%) | 0 (0%) |
| α2-MO | 42 | 1 (2%) | 41 (98%) |
| NCX4a-MO | 19 | 2 (11%) | 17 (89%) |
| α2-MO+KN62 | 24 | 17 (71%) | 7 (29%) |